Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation.

Journal of Experimental & Clinical Cancer Research : CR
Zhihui DouHong Zhang

Abstract

Bcl-x pre-mRNA splicing serves as a typical example to study the impact of alternative splicing in the modulation of cell death. Dysregulation of Bcl-x apoptotic isoforms caused by precarious equilibrium splicing is implicated in genesis and development of multiple human diseases, especially cancers. Exploring the mechanism of Bcl-x splicing and regulation has provided insight into the development of drugs that could contribute to sensitivity of cancer cells to death. On this basis, we review the multiple splicing patterns and structural characteristics of Bcl-x. Additionally, we outline the cis-regulatory elements, trans-acting factors as well as epigenetic modifications involved in the splicing regulation of Bcl-x. Furthermore, this review highlights aberrant splicing of Bcl-x involved in apoptosis evade, autophagy, metastasis, and therapy resistance of various cancer cells. Last, emphasis is given to the clinical role of targeting Bcl-x splicing correction in human cancer based on the splice-switching oligonucleotides, small molecular modulators and BH3 mimetics. Thus, it is highlighting significance of aberrant splicing isoforms of Bcl-x as targets for cancer therapy.

References

Mar 1, 1996·British Journal of Haematology·L XerriD Birnbaum
Jul 24, 1998·Biochemical and Biophysical Research Communications·J BanE Tschachler
Sep 22, 1999·Molecular and Cellular Biology·B S ChangC B Thompson
Nov 24, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·H StrikR Meyermann
May 17, 2000·Pharmaceutica acta Helvetiae·P Schneider, J Tschopp
Jun 30, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T TakeharaH Takahashi
Apr 13, 2002·Journal of Neuro-oncology·Johannes R StrefferMichael Weller
Oct 17, 2002·The Journal of Biological Chemistry·Danielle R MercatanteRyszard Kole
Apr 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ian J AmannaColleen E Hayes
Dec 31, 2004·Cell Research·Chang You LiJiu Yong Xie
Jun 2, 2005·British Journal of Cancer·P NixN Stafford
Aug 6, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mads Hald AndersenPer thor Straten
Sep 24, 2005·Cell·Sophie PattingreBeth Levine
Jun 23, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Autumn MassielloCharles E Chalfant
Mar 21, 2007·The Journal of Cell Biology·Maria Paola ParonettoClaudio Sette
Jun 15, 2007·Toxicologic Pathology·Susan Elmore
Jul 27, 2007·Investigative Ophthalmology & Visual Science·Nanfei ZhangGlenn J Jaffe
Oct 10, 2007·Molecular and Cellular Biology·Timothée RevilBenoit Chabot
Jul 30, 2008·Molecular and Cellular Biology·Anyu ZhouShu-Ching Huang
Sep 25, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Annemieke Aartsma-RusGert-Jan B van Ommen
Oct 25, 2008·Nature·Evripidis GavathiotisLoren D Walensky
Feb 21, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Min H Kang, C Patrick Reynolds
Feb 26, 2009·Cell·Markus C WahlReinhard Lührmann
Jun 13, 2009·The Journal of Biological Chemistry·Timothée RevilBenoit Chabot
Feb 25, 2010·Journal of Experimental & Clinical Cancer Research : CR·Xiaoxin MaYuanqi He
Aug 14, 2010·Cell·Michael J MoorePamela A Silver
Aug 20, 2010·Nucleic Acids Research·John A BaumanRyszard Kole
Oct 29, 2010·The Journal of Biological Chemistry·Lulzim ShkretaBenoit Chabot

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms